Shortage reports
Actual shortage:
17 (12%)
Anticipated shortage:
0 (0%)
Avoided shortage:
1 (1%)
Resolved:
125 (87%)
143
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
29 (100%)
Reversed:
0 (0%)
29
34 (20%)
15 (88%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-LOSARTAN | 100.0MG | TABLET | Resolved | 2020-04-25 | 2024-12-05 | 113190 |
| MINT-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2021-10-21 | 2023-04-01 | 147787 |
| MINT-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2019-02-04 | 2020-01-27 | 74450 |
| MINT-LOSARTAN/HCTZ | 50MG 12.5MG | TABLET | Resolved | 2020-04-25 | 2020-07-13 | 113193 |
| MINT-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2021-10-21 | 2024-12-05 | 147784 |
| MINT-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-04-08 | 2020-07-13 | 80808 |
| MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Resolved | 2019-04-08 | 2020-07-13 | 80811 |
| MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Resolved | 2021-10-21 | 2024-12-05 | 147790 |
| MINT-METFORMIN | 500MG | TABLET | Resolved | 2019-02-04 | 2024-12-05 | 74455 |
| MINT-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-04-12 | 2018-05-04 | 45542 |
| MINT-OLANZAPINE | 2.5MG | TABLET | Resolved | 2020-08-19 | 2020-10-27 | 122521 |
| MINT-OLANZAPINE | 5MG | TABLET | Resolved | 2020-08-19 | 2020-10-27 | 122524 |
| MINT-OLANZAPINE | 10MG | TABLET | Resolved | 2020-08-19 | 2020-10-27 | 122527 |
| MINT-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35467 |
| MINT-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108295 |
| MINT-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35470 |
| MINT-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108298 |
| MINT-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35473 |
| MINT-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108301 |
| MINT-ONDANSETRON | 8MG | TABLET | Resolved | 2017-10-26 | 2017-11-22 | 27173 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
| MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
| MINT-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95907 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95903 |
| MINT-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95900 |
| MINT-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95897 |
| MINT-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95913 |
| MINT-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95916 |
| MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |